SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-24-016016
Filing Date
2024-02-15
Accepted
2024-02-15 17:22:26
Documents
77
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-K prld-20231231.htm   iXBRL 10-K 2370347
2 EX-4.4 prld-ex4_4.htm EX-4.4 156245
3 EX-4.5 prld-ex4_5.htm EX-4.5 65207
4 EX-10.7 prld-ex10_7.htm EX-10.7 112967
5 EX-10.13 prld-ex10_13.htm EX-10.13 233515
6 EX-21.1 prld-ex21_1.htm EX-21.1 2061
7 EX-23.1 prld-ex23_1.htm EX-23.1 6569
8 EX-31.1 prld-ex31_1.htm EX-31.1 12752
9 EX-31.2 prld-ex31_2.htm EX-31.2 12799
10 EX-32.1 prld-ex32_1.htm EX-32.1 9780
11 EX-32.2 prld-ex32_2.htm EX-32.2 8545
12 EX-97.1 prld-ex97_1.htm EX-97.1 81321
13 GRAPHIC img16744241_0.jpg GRAPHIC 104941
14 GRAPHIC img16744241_1.jpg GRAPHIC 38747
15 GRAPHIC img16744241_2.jpg GRAPHIC 33153
16 GRAPHIC img16744241_3.jpg GRAPHIC 43711
  Complete submission text file 0000950170-24-016016.txt   9861828

Data Files

Seq Description Document Type Size
17 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT prld-20231231.xsd EX-101.SCH 1204473
78 EXTRACTED XBRL INSTANCE DOCUMENT prld-20231231_htm.xml XML 1355654
Mailing Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805
Business Address 175 INNOVATION BOULEVARD WILMINGTON DE 19805 (302) 467-1280
Prelude Therapeutics Inc (Filer) CIK: 0001678660 (see all company filings)

IRS No.: 811384762 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-39527 | Film No.: 24644902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)